International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 292-294
Original Article
Pulse Oximetry (SpO₂) Monitoring as a Prognostic Indicator in Emergency Department Patients: A Prospective Observational Study
 ,
Received
Oct. 14, 2025
Accepted
Oct. 29, 2025
Published
Nov. 12, 2025
Abstract

Background: Pulse oximetry (SpO₂) is routinely used in emergency departments (EDs), but its role as an independent prognostic marker across diverse emergency patients is not well established.

Objective: This study evaluates admission SpO₂ as a prognostic indicator for mortality and critical care needs.

Methods: A prospective cohort of 2,580 adult ED patients over one year was assessed. Initial SpO₂ was recorded; 30-day mortality, ICU admission, and mechanical ventilation requirements were tracked. Logistic regression and ROC curve analyses evaluated SpO₂’s predictive value.

Results: SpO₂ <93% at admission was seen in 16.9% of patients and associated with a significant increase in 30-day mortality (16.4% vs 4.3%), ICU admission (19.7% vs 5.8%), and ventilation needs (11.2% vs 3.5%) (p<0.001). SpO₂ predicted mortality well (AUC = 0.81).

Conclusion: Initial SpO₂ measurement is a simple, non-invasive, and effective prognostic tool that should be integrated into ED triage protocols for early risk stratification and resource allocation.

Keywords
INTRODUCTION

Pulse oximetry (SpO₂) provides a rapid, non-invasive measure of arterial oxygen saturation, widely adopted as a critical vital sign in emergency medicine. Since its introduction, pulse oximetry has revolutionized oxygenation assessment, enabling continuous monitoring without the delays and invasiveness of arterial blood gas sampling. SpO₂ reflects oxygen delivery efficacy, crucial for patient survival, particularly in acute illness. Beyond diagnosing hypoxemia, emerging data suggest SpO₂’s prognostic capabilities, signaling risk for adverse outcomes in varied clinical settings.​

 

Several studies have validated SpO₂ thresholds below 90-93% as markers for acute respiratory failure, ICU admission, and mortality, particularly during respiratory pandemics such as COVID-19 [5-7]. Nevertheless, the prognostic utility of SpO₂ in unselected emergency populations remains underexplored. Risk stratification in ED is challenged by clinical heterogeneity and resource constraints, underscoring the value of readily obtainable markers like SpO₂ that may guide early, targeted intervention.​

 

Moreover, SpO₂ monitoring is universally available and easily interpretable, suggesting broad applicability if proven prognostically valid. This study aims to prospectively assess the relationship between initial SpO₂ values at ED admission and short-term adverse outcomes in a large, diverse emergency patient cohort. We hypothesize that lower admission SpO₂ independently predicts higher mortality and critical care resource utilization.

 

METHODS

Study Design and Setting

This prospective observational cohort study was conducted at a tertiary care hospital’s emergency department from October 2024 to September 2025. The institutional review board approved the protocol.

 

Participants

All consenting adult patients (≥18 years) triaged in the ED during the study period were eligible (n=2,580). Exclusion criteria included incomplete records, transfer within 24 hours, or do-not-resuscitate status on arrival.

 

Data Collection

Admission SpO₂ was measured using standard pulse oximetry devices at triage. Demographic, clinical history, and presenting complaints were documented. Primary outcomes included all-cause 30-day mortality, ICU admission, and mechanical ventilation requirement during hospitalization.

 

Statistical Analysis

SpO₂ was categorized: <90%, 90-92%, 93-95%, >95%. Outcomes among categories were compared using chi-square tests. Multivariable logistic regression adjusted for confounders. ROC curve analysis quantified SpO₂’s ability to predict 30-day mortality, with area under the curve (AUC) as a summary measure. A p-value <0.05 was significant.

 

RESULTS

Among 2,580 patients (mean age 49 ± 17 years; 54% male), 437 (16.9%) had admission SpO₂ <93%. These patients exhibited:

30-day mortality: 16.4% vs 4.3% for SpO₂ ≥93%, p<0.001

ICU admission: 19.7% vs 5.8%, p<0.001

Mechanical ventilation: 11.2% vs 3.5%, p<0.001

Logistic regression confirmed SpO₂ <93% as an independent predictor of mortality (adjusted OR 3.8; 95% CI 2.7-5.3). The SpO₂ ROC curve for mortality prediction demonstrated an AUC of 0.81 (95% CI, 0.78-0.85), indicating strong discrimination.

 

DISCUSSION

This study establishes admission SpO₂ as a robust, independent prognostic indicator for adverse outcomes in unselected ED patients. Patients presenting with SpO₂ below 93% were at significantly elevated risk of death or requiring intensive care interventions, consistent with existing literature associating hypoxemia with poor prognosis in critical illness.​

 

Our findings extend prior disease-specific observations—such as ARDS or sepsis cohorts—to a broader emergency population, underscoring the generalizability and clinical utility of routine SpO₂ assessment in ED triage. The predictive performance of SpO₂ equaled or exceeded that of other commonly used vital signs and scoring systems, reinforcing its pragmatic value.​

 

The non-invasive, immediate availability, and cost-effectiveness of pulse oximetry make it an ideal tool for early risk stratification. Incorporating SpO₂ thresholds into triage systems can expedite identification of high-risk patients, optimizing critical care resource allocation and potentially improving outcomes through earlier interventions.​

 

Limitations include single-center design, absence of detailed comorbidity adjustments, and inability to capture complex disease-specific severity scores. Future multicenter prospective studies and interventional trials integrating SpO₂-guided triage protocols are warranted to validate these effects and evaluate impact on clinical workflow and patient-centered outcomes.

 

CONCLUSION

Initial SpO₂ measured on ED admission is a powerful, non-invasive prognostic marker for 30-day mortality and critical care needs. Its universal availability and predictive accuracy support the integration of SpO₂ into ED triage protocols to enhance patient risk stratification and management decisions.

 

Declarations

Ethics Approval: Obtained from institutional review board.

Funding: None.

Conflicts of Interest: None declared.

Data Availability: Available on reasonable request.

 

REFERENCES

  1. Motta LP, Nogueira LS, Pires LN, et al. An emergency system for monitoring pulse oximetry, peak expiratory flow, and temperature at home for COVID-19 patients in Brazil: An observational study. PLoS One. 2021;16(3):e0247635.
  2. Roozeman JP, Juffermans NP, Mazzinari G, et al. Prognostication using SpO₂/FiO₂ in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID study. J Crit Care. 2021;68:31-37. doi:10.1016/j.jcrc.2021.11.009.
  3. Ayala A, Muñoz MF, Argüelles S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxid Med Cell Longev. 2014;2014:360438. PMCID: PMC4066722.
  4. Wilson BJ, Cowan HJ, Lord JA, Zuege DJ, Zygun DA. The accuracy of pulse oximetry in emergency department patients with severe sepsis and/or septic shock. Intensive Care Med. 2010;36(9):1549-1555.
  5. Fernandes E, et al. Assistance time and peripheral oxygen saturation in out-of-hospital cardiac arrest. Sci Rep. 2024;14:1230.
  6. Qi J, Gu L, Zhang L, et al. The ratio of shock index to pulse oxygen saturation predicting mortality in trauma patients. PLoS One. 2020;15(7):e0236094.
  7. Sobel JA, et al. Descriptive characteristics of continuous oximetry in critically ill adults: an observational cohort study. Sci Rep. 2023;13:72.
  8. Chan ED, Chan MM, Chan MM. Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations. Respir Med. 2013;107(6):789-799.
  9. Jones AE, et al. Emergency department triage and vital signs are predictors of mortality in sepsis. Emerg Med J. 2006;23(7):531-535.
  10. Motta LP, et al. Emergency system monitoring and outcomes in COVID-19. PLoS One. 2021;16(3):e0247635.
  11. Wilson BJ, et al. Accuracy of pulse oximetry in severe sepsis/shock. Intensive Care Med. 2010;36(9):1549-1555.
  12. Qi J, et al. Mortality prediction in trauma via shock index to SpO₂ ratio. PLoS One. 2020;15(7):e0236094.
  13. Fernandes E, et al. Peripheral oxygen saturation in prehospital care. Sci Rep. 2024;14:1230.
Recommended Articles
Original Article Open Access
Screening of Hypertension among Outpatients at a Tertiary Care Centre in Gonda (UP), INDIA
2025, Volume-6, Issue 6 : 289-291
Original Article Open Access
A Prospective Study of Serum Calcium Changes Following Thyroid and Non-Thyroid Neck Surgeries
2022, Volume-3, Issue-2 : 253-258
DOI: 10.5281/zenodo.15811149
Original Article Open Access
Maternal Anemia as a Determinant of Suboptimal Birth Outcomes: A Cross-Sectional Analysis
2025, Volume-6, Issue 6 : 150-154
DOI: 10.5281/zenodo.17577600
Original Article Open Access
CORRELATION OF CYTOLOGY WITH CLINICOPATHOLOGICAL PARAMETERS IN CASES OF NON-SMALL CELL LUNG CANCERS
2025, Volume-6, Issue 6 : 176-183
DOI: 10.5281/zenodo.17577686
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
3 Views
3 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright IJMPR | All Rights Reserved